• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在澳大利亚和新西兰,从维持性血液透析转为腹膜透析患者的预测因素和结局:强化“腹膜透析优先”政策的论据。

Predictors and outcomes of patients switching from maintenance haemodialysis to peritoneal dialysis in Australia and New Zealand: Strengthening the argument for 'peritoneal dialysis first' policy.

机构信息

University of Medicine and Pharmacy Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Nephrology Department, Cho Ray Hospital, Vietnam.

出版信息

Nephrology (Carlton). 2019 Sep;24(9):958-966. doi: 10.1111/nep.13512. Epub 2019 May 2.

DOI:10.1111/nep.13512
PMID:30328210
Abstract

AIMS

(1) To determine incidence and reasons for transfer from maintenance haemodialysis (HD) to peritoneal dialysis (PD); (2) To compare mortality of HD patients transferred to PD with those who initiated and remained on PD.

METHODS

A 1:2 matched cohort of ANZDATA included patients dialyzing over 3 months dividing into 2 groups. Group A (HD to PD) was compared to group B (initiated and remained on PD) and matched PD group (Group C). We compared mortality by total time on dialysis regardless of modality.

RESULTS

Of 20 882 patients, there were 911 in group A. The transfer rate from HD to PD was 5%, 6.7% and 7.4% at 1,4 and 8 years, respectively. Median time before switching of patients in Group A was 5.9 (4.0-10.9) months. The commonest reported reason for transfer was patient preference (63.8%). Mortality was significantly worse in Group A if dialysis vintage was ≤6 months and from 12-24 months (P < 0.05), whereas there was no difference in mortality if dialysis vintage was 6-12 months or ≥ 24 months (P = 0.073 and P = 0.153, respectively). Overall, mortality of patients in group A was higher than that in group B after adjusting for age, race, chronic lung disease, peripheral vascular disease, cerebrovascular disease, diabetes, haemoglobin and phosphate (hazard ratio = 1.335, 95% confidence interval = 1.172-1.520).

CONCLUSION

Haemodialysis patients transferred to PD had higher mortality than those initiated on PD, strengthening the case for PD first policy.

摘要

目的

(1) 确定从维持性血液透析(HD)转为腹膜透析(PD)的发生率和原因;(2) 比较转至 PD 的 HD 患者与起始并持续 PD 患者的死亡率。

方法

ANZDATA 包含超过 3 个月透析的患者,将其分为 2 组。A 组(HD 转 PD)与 B 组(起始并持续 PD)和匹配的 PD 组(C 组)进行比较。我们比较了无论透析方式如何,整个透析时间的死亡率。

结果

在 20882 名患者中,A 组有 911 名患者。HD 转 PD 的转归率分别为 1 年、4 年和 8 年时的 5%、6.7%和 7.4%。A 组患者在开始转换前的中位时间为 5.9(4.0-10.9)个月。转至 PD 的最常见报告原因是患者偏好(63.8%)。如果透析龄≤6 个月和 12-24 个月(P<0.05),A 组的死亡率显著更差,而如果透析龄为 6-12 个月或≥24 个月(P=0.073 和 P=0.153),死亡率则没有差异。总体而言,在调整年龄、种族、慢性肺部疾病、外周血管疾病、脑血管疾病、糖尿病、血红蛋白和磷酸盐后,A 组患者的死亡率高于 B 组(危险比=1.335,95%置信区间=1.172-1.520)。

结论

转至 PD 的 HD 患者的死亡率高于起始 PD 的患者,这加强了 PD 优先政策的理由。

相似文献

1
Predictors and outcomes of patients switching from maintenance haemodialysis to peritoneal dialysis in Australia and New Zealand: Strengthening the argument for 'peritoneal dialysis first' policy.在澳大利亚和新西兰,从维持性血液透析转为腹膜透析患者的预测因素和结局:强化“腹膜透析优先”政策的论据。
Nephrology (Carlton). 2019 Sep;24(9):958-966. doi: 10.1111/nep.13512. Epub 2019 May 2.
2
Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.急性非计划性腹膜透析与血液透析的可比结局。
Nephrol Dial Transplant. 2012 Jan;27(1):375-80. doi: 10.1093/ndt/gfr262. Epub 2011 May 28.
3
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.腹膜透析时的高膜转运状态与转为血液透析后的生存降低无关。
Nephrol Dial Transplant. 2007 Oct;22(10):3005-12. doi: 10.1093/ndt/gfm324. Epub 2007 Jun 2.
4
Comparison of the risk of non-traumatic lower extremity amputation between haemodialysis and peritoneal dialysis patients with end-stage renal disease.终末期肾病血液透析和腹膜透析患者非创伤性下肢截肢风险的比较。
Nephrology (Carlton). 2018 Jan;23(1):86-92. doi: 10.1111/nep.12946.
5
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.澳大利亚和新西兰初治透析患者的透析方式与感染性死亡率的关联
Am J Kidney Dis. 2009 Feb;53(2):290-7. doi: 10.1053/j.ajkd.2008.06.032. Epub 2008 Sep 21.
6
Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.中心效应与腹膜透析相关性腹膜炎结局:全国登记数据分析。
Am J Kidney Dis. 2018 Jun;71(6):814-821. doi: 10.1053/j.ajkd.2017.10.017. Epub 2017 Dec 28.
7
Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis.因腹膜炎进行临时血液透析转换后的腹膜透析结局
Nephrol Dial Transplant. 2014 Oct;29(10):1940-7. doi: 10.1093/ndt/gfu050. Epub 2014 Mar 3.
8
Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.腹膜透析第一年的技术失败风险预测因素和原因:澳大利亚和新西兰透析和移植登记处(ANZDATA)研究。
Am J Kidney Dis. 2018 Aug;72(2):188-197. doi: 10.1053/j.ajkd.2017.10.019. Epub 2017 Dec 23.
9
Socioeconomic status and dialysis quality of care.社会经济地位与透析质量的关系。
Nephrology (Carlton). 2020 May;25(5):421-428. doi: 10.1111/nep.13629. Epub 2019 Jul 21.
10
Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis.老年透析患者的生活质量与身体功能:辅助性腹膜透析与血液透析的比较
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):423-30. doi: 10.2215/CJN.01050115. Epub 2015 Dec 28.

引用本文的文献

1
Peritoneal Dialysis Technique Survival: A Cohort Study.腹膜透析技术生存率:一项队列研究。
Am J Kidney Dis. 2024 Sep;84(3):298-305.e1. doi: 10.1053/j.ajkd.2024.03.012. Epub 2024 Apr 17.
2
Rate and reasons for peritoneal dialysis dropout following haemodialysis to peritoneal dialysis switch: a systematic review and meta-analysis.血液透析转换至腹膜透析后腹膜透析退出的比率和原因:系统评价和荟萃分析。
BMC Nephrol. 2024 Mar 16;25(1):99. doi: 10.1186/s12882-024-03542-w.
3
Albumin-globulin ratio and mortality in patients on peritoneal dialysis: a retrospective study.
腹膜透析患者的白蛋白-球蛋白比值与死亡率:一项回顾性研究。
BMC Nephrol. 2020 Feb 14;21(1):51. doi: 10.1186/s12882-020-1707-1.
4
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices?透析报销:不同模式对临床选择有何影响?
J Clin Med. 2019 Feb 25;8(2):276. doi: 10.3390/jcm8020276.